☆Opaleye Management Inc.
Quality Q
0.496
AUM ($M)
1,104
Positions
58
Turnover
0.23
Top-10 wt
65%
Herfindahl
0.065
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 67 positions · portfolio value $1,104M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆LQDA funds › | LIQUIDIA CORPORATION | TRIM | — | 17.7% | +6.0% | 195.1 | 2,447,500 | -97,500 | 5 | — |
| ☆ETON funds › | ETON PHARMACEUTICALS INC | HOLD | — | 9.4% | +0.1% | 103.5 | 2,860,000 | +0 | 5 | — |
| ☆HROW funds › | HARROW INC | TRIM | — | 9.2% | -3.9% | 101.9 | 2,400,000 | -432,230 | 5 | — |
| ☆IRON funds › | DISC MEDICINE INC | ADD | — | 5.7% | +2.1% | 62.5 | 855,000 | +434,000 | 5 | — |
| ☆URGN funds › | UROGEN PHARMA LTD | ADD | — | 4.8% | +1.4% | 53.0 | 1,439,996 | +9,996 | 3 | — |
| ☆APGE funds › | APOGEE THERAPEUTICS INC | HOLD | — | 4.7% | +0.4% | 51.8 | 390,000 | +0 | 4 | — |
| ☆MGTX funds › | MEIRAGTX HLDGS PLC | ADD | — | 4.3% | +1.9% | 48.0 | 3,550,000 | +1,426,741 | 3 | — |
| ☆SLGL funds › | SOL-GEL TECHNOLOGIES LTD | HOLD | — | 3.4% | -1.9% | 37.1 | 500,000 | +0 | 4 | — |
| ☆RZLT funds › | REZOLUTE INC | HOLD | — | 3.0% | +0.4% | 32.8 | 6,300,000 | +0 | 5 | — |
| ☆TGTX funds › | TG THERAPEUTICS INC | HOLD | — | 2.7% | +0.3% | 29.4 | 535,000 | +0 | 5 | — |
| ☆IMMX funds › | IMMIX BIOPHARMA INC | NEW | — | 2.2% | +2.2% | 24.2 | 2,345,000 | +2,345,000 | 1 | — |
| ☆CBIO funds › | CRESCENT BIOPHARMA INC. | ADD | — | 2.2% | -1.0% | 23.7 | 1,319,351 | +6,736 | 3 | — |
| ☆STOK funds › | STOKE THERAPEUTICS INC | HOLD | — | 2.1% | -0.9% | 22.9 | 700,000 | +0 | 5 | — |
| ☆ACOG funds › | ALPHA COGNITION INC | ADD | — | 1.9% | +0.0% | 20.9 | 2,895,467 | +333,517 | 4 | — |
| ☆EWTX funds › | EDGEWISE THERAPEUTICS INC | HOLD | — | 1.8% | -0.2% | 20.3 | 500,000 | +0 | 5 | — |
| ☆RVMD funds › | REVOLUTION MEDICINES INC | HOLD | — | 1.7% | +0.4% | 18.7 | 100,000 | +0 | 5 | — |
| ☆GLUE funds › | MONTE ROSA THERAPEUTICS INC | NEW | — | 1.6% | +1.6% | 18.0 | 745,000 | +745,000 | 1 | — |
| ☆ALMS funds › | ALUMIS INC | HOLD | — | 1.4% | -0.2% | 15.5 | 550,000 | +0 | 5 | — |
| ☆CDXS funds › | CODEXIS INC | HOLD | — | 1.4% | -0.1% | 15.3 | 6,785,000 | +0 | 5 | — |
| ☆REPL funds › | REPLIMUNE GROUP INC | NEW | — | 1.4% | +1.4% | 15.3 | 1,384,993 | +1,384,993 | 1 | — |
| ☆XOMA funds › | XOMA ROYALTY CORPORATION | ADD | — | 1.3% | +0.1% | 14.4 | 338,374 | +38,374 | 5 | — |
| ☆MBX funds › | MBX BIOSCIENCES INC | HOLD | — | 1.3% | +0.3% | 14.4 | 260,000 | +0 | 5 | — |
| ☆RYTM funds › | RHYTHM PHARMACEUTICALS INC | TRIM | — | 1.2% | -3.4% | 13.6 | 122,500 | -500 | 5 | — |
| ☆EDIT funds › | EDITAS MEDICINE INC | ADD | — | 1.1% | +0.5% | 12.5 | 3,861,930 | +1,934,933 | 2 | — |
| ☆PTGX funds › | PROTAGONIST THERAPEUTICS INC | HOLD | — | 1.1% | -0.3% | 12.3 | 100,000 | +0 | 5 | — |
| ☆CABA funds › | CABALETTA BIO INC | ADD | — | 1.1% | +0.6% | 12.0 | 3,863,800 | +2,483,800 | 4 | — |
| ☆QTTB funds › | Q32 BIO INC | TRIM | — | 1.1% | +0.0% | 11.9 | 931,000 | -325,228 | 3 | — |
| ☆ANNX funds › | ANNEXON INC | TRIM | — | 0.9% | -0.8% | 9.8 | 1,714,451 | -617,310 | 4 | — |
| ☆VSTM funds › | VERASTEM INC | NEW | — | 0.6% | +0.6% | 6.9 | 1,800,000 | +1,800,000 | 1 | — |
| ☆ZNTL funds › | ZENTALIS PHARMACEUTICALS INC | HOLD | — | 0.6% | +0.2% | 6.9 | 1,412,656 | +0 | 5 | — |
| ☆RLMD funds › | RELMADA THERAPEUTICS INC | HOLD | — | 0.6% | -0.3% | 6.5 | 935,000 | +0 | 3 | — |
| ☆OCUL funds › | OCULAR THERAPEUTIX INC | HOLD | — | 0.5% | -0.1% | 5.9 | 600,000 | +0 | 5 | — |
| ☆TRVI funds › | TREVI THERAPEUTICS INC | TRIM | — | 0.5% | -0.0% | 5.8 | 310,000 | -35,100 | 5 | — |
| ☆BBOT funds › | BRIDGEBIO ONCOLOGY THERAPEUT | ADD | — | 0.5% | +0.4% | 5.3 | 700,000 | +646,718 | 2 | — |
| ☆LYEL funds › | LYELL IMMUNOPHARMA INC | ADD | — | 0.4% | +0.2% | 4.8 | 344,025 | +264,928 | 2 | — |
| ☆IRD funds › | OPUS GENETICS INC | ADD | — | 0.4% | +0.1% | 4.6 | 1,125,000 | +5,000 | 5 | — |
| ☆FDMT funds › | 4D MOLECULAR THERAPEUTICS IN | ADD | — | 0.4% | +0.3% | 4.4 | 334,437 | +222,146 | 2 | — |
| ☆NTLA funds › | INTELLIA THERAPEUTICS INC | ADD | — | 0.4% | -0.0% | 4.2 | 250,000 | +5,000 | 2 | — |
| ☆VYGR funds › | VOYAGER THERAPEUTICS INC | ADD | — | 0.4% | -0.2% | 4.1 | 1,185,000 | +35,000 | 3 | — |
| ☆BDSX funds › | BIODESIX INC | TRIM | — | 0.4% | -0.1% | 4.1 | 180,000 | -58,047 | 2 | — |
| ☆RCKT funds › | ROCKET PHARMACEUTICALS INC | ADD | — | 0.3% | -0.1% | 3.4 | 1,000,000 | +45,000 | 3 | — |
| ☆JBIO funds › | JADE BIOSCIENCES INC | TRIM | — | 0.3% | -0.5% | 3.2 | 145,000 | -282,608 | 3 | — |
| ☆CUSIP:80303D305 funds › | SANUWAVE HEALTH INC | TRIM | — | 0.3% | -2.0% | 3.1 | 306,140 | -675,127 | 5 | — |
| ☆FBIO funds › | FORTRESS BIOTECH INC | TRIM | — | 0.2% | -0.1% | 2.7 | 890,000 | -152,000 | 3 | — |
| ☆DERM funds › | JOURNEY MED CORP | TRIM | — | 0.2% | -0.4% | 2.5 | 350,000 | -610,000 | 5 | — |
| ☆PHAT funds › | PHATHOM PHARMACEUTICALS INC | NEW | — | 0.2% | +0.2% | 2.0 | 185,589 | +185,589 | 1 | — |
| ☆INBX funds › | INHIBRX BIOSCIENCES INC | NEW | — | 0.2% | +0.2% | 1.9 | 20,291 | +20,291 | 1 | — |
| ☆ENTA funds › | ENANTA PHARMACEUTICALS INC | HOLD | — | 0.2% | -0.0% | 1.8 | 125,000 | +0 | 3 | — |
| ☆COAG funds › | HEMAB THERAPEUTICS HLDGS INC | NEW | — | 0.2% | +0.2% | 1.8 | 47,652 | +47,652 | 1 | — |
| ☆TRAX funds › | FIRST TRACKS BIOTHERAPEUTICS | NEW | — | 0.1% | +0.1% | 1.3 | 65,000 | +65,000 | 1 | — |
| ☆CGON funds › | CG ONCOLOGY INC | TRIM | — | 0.1% | -0.7% | 1.3 | 17,789 | -77,011 | 5 | — |
| ☆BHVN funds › | BIOHAVEN LTD | NEW | — | 0.1% | +0.1% | 1.2 | 77,915 | +77,915 | 1 | — |
| ☆AVIR funds › | ATEA PHARMACEUTICALS INC | TRIM | — | 0.1% | -0.1% | 1.1 | 235,000 | -87,600 | 3 | — |
| ☆KTTA funds › | PASITHEA THERAPEUTICS CORP | NEW | — | 0.1% | +0.1% | 1.1 | 2,050,000 | +2,050,000 | 1 | — |
| ☆ADCT funds › | ADC THERAPEUTICS SA | NEW | — | 0.1% | +0.1% | 0.7 | 700,000 | +700,000 | 1 | — |
| ☆OKYO funds › | OKYO PHARMA LTD | NEW | — | 0.1% | +0.1% | 0.6 | 375,204 | +375,204 | 1 | — |
| ☆PTN funds › | PALATIN TECHNOLOGIES INC | NEW | — | 0.0% | +0.0% | 0.2 | 20,500 | +20,500 | 1 | — |
| ☆ADGM funds › | ADAGIO MED HLDGS INC | HOLD | — | 0.0% | -0.0% | 0.0 | 18,444 | +0 | 5 | — |
| ☆TECX funds › | TECTONIC THERAPEUTIC INC | EXIT | — | 0.0% | -0.5% | 0.0 | 0 | -123,000 | 0 | — |
| ☆STRO funds › | SUTRO BIOPHARMA INC | EXIT | — | 0.0% | -0.6% | 0.0 | 0 | -190,671 | 0 | — |
| ☆LBRX funds › | LB PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -14,506 | 0 | — |
| ☆NXTC funds › | NEXTCURE INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -141,181 | 0 | — |
| ☆RIGL funds › | RIGEL PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -70,000 | 0 | — |
| ☆CUSIP:04546C304 funds › | ASSERTIO HOLDINGS INC | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -265,707 | 0 | — |
| ☆CATX funds › | PERSPECTIVE THERAPEUTICS INC | EXIT | — | 0.0% | -2.6% | 0.0 | 0 | -4,675,000 | 0 | — |
| ☆CUSIP:46489V902 funds › | PERSPECTIVE THERAPEUTICS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -200,000 | 0 | — |
| ☆PLX funds › | PROTALIX BIOTHERAPEUTICS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -340,000 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 1,104 | 58 | 0.23 | 65% | 0.065 | 0.494 | — | in |
| 2026Q1 | 759 | 54 | 0.24 | 61% | 0.057 | 0.397 | — | in |
| 2025Q4 | 758 | 54 | 0.23 | 65% | 0.093 | 0.396 | — | in |
| 2025Q3 | 707 | 43 | 0.18 | 73% | 0.103 | 0.571 | — | in |
| 2025Q2 | 499 | 41 | 0.12 | 73% | 0.090 | 0.673 | — | entered |
| 2025Q1 | 449 | 45 | 0.00 | 74% | 0.089 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status